<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 12.5: HLA Typing and Genetic Predisposition Testing</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - BLUE theme for Advanced Testing */
        .module-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #1e3a8a;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e3a8a;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #eff6ff;
            border: 2px solid #3b82f6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #d8dce0;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #3b82f6;
        }

        .term-item .term {
            font-weight: 700;
            color: #1e3a8a;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e3a8a;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
            letter-spacing: 0.5px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #3b82f6, #1e3a8a);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            flex-shrink: 0;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            position: relative;
            overflow: hidden;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
            position: relative;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 42px;
            font-weight: 700;
            color: white;
            line-height: 1;
            margin-bottom: 8px;
        }

        .stat-label {
            font-size: 13px;
            color: rgba(255, 255, 255, 0.85);
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        /* Table Style */
        .data-table-container {
            overflow-x: auto;
            margin: 35px 0;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        .data-table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            background: white;
        }

        .data-table th {
            background: #f8fafc;
            color: #1e3a8a;
            font-weight: 700;
            text-align: left;
            padding: 16px;
            border-bottom: 2px solid #e5e7eb;
        }

        .data-table td {
            padding: 16px;
            border-bottom: 1px solid #f1f5f9;
            color: #4b5563;
        }

        .data-table tr:last-child td {
            border-bottom: none;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .check-understanding .box-label {
            font-weight: 600;
            color: #8B6914;
            margin: 0 0 8px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
            position: relative;
        }

        .reveal-btn {
            background: #1e3a8a;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            font-size: 14px;
            cursor: pointer;
            font-family: inherit;
        }

        .answer-text {
            display: none;
            font-size: 14px;
            color: #1e3a8a;
            margin: 14px 0 0 0;
            padding: 14px;
            background: #eff6ff;
            border-radius: 8px;
        }

        .answer-text.show {
            display: block;
        }

        /* Takeaways */
        .takeaways-box {
            background: linear-gradient(135deg, #f5f5f5 0%, #e8e8e8 100%);
            padding: 22px 25px;
            margin-top: 35px;
            border-radius: 8px;
            border: 1px solid #ddd;
        }

        .takeaways-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 15px 0;
            font-size: 16px;
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        /* References Box */
        .references-box {
            margin-top: 40px;
            padding: 25px;
            background: #f9f9f9;
            border-radius: 12px;
            font-size: 14px;
            color: #666;
            border: 1px solid #eee;
        }

        .references-box h4 {
            margin: 0 0 15px 0;
            color: #333;
            font-size: 16px;
        }

        .references-list {
            list-style: none;
            padding: 0;
            margin: 0;
        }

        .references-list li {
            margin-bottom: 8px;
            line-height: 1.5;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            height: auto;
            margin-bottom: 15px;
            opacity: 0.9;
        }

        .lesson-footer .brand {
            color: #1e3a8a;
            font-weight: 600;
            margin: 0;
            font-size: 15px;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 12: Advanced Testing & Biomarker Analysis</p>
            <h1 class="lesson-title">Lesson 12.5: HLA Typing and Genetic Predisposition Testing</h1>
            <div class="lesson-meta">
                <span class="meta-item">32 min read</span>
                <span class="meta-item">Lesson 5 of 8</span>
            </div>
        </header>

        <!-- Table of Contents -->
        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>The Architecture of MHC</a></li>
                <li><a href="#section2"><span class="section-num">2</span>The HLA-Autoimmunity Link</a></li>
                <li><a href="#section3"><span class="section-num">3</span>Celiac: DQ2/DQ8 Interpretation</a></li>
                <li><a href="#section4"><span class="section-num">4</span>HLA-B27 & Spondyloarthropathy</a></li>
                <li><a href="#section5"><span class="section-num">5</span>Genetic Load vs. Epigenetic Triggers</a></li>
                <li><a href="#section6"><span class="section-num">6</span>Clinical Application in A.R.M.O.R.</a></li>
            </ul>
        </div>

        <!-- Learning Objectives -->
        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Explain the role of the Human Leukocyte Antigen (HLA) system in immune self-tolerance.</li>
                <li>Identify high-risk HLA alleles for Celiac, Rheumatoid Arthritis, and Ankylosing Spondylitis.</li>
                <li>Differentiate between diagnostic confirmation and genetic predisposition.</li>
                <li>Utilize HLA typing within the <strong>Antigen Mapping</strong> phase of the A.R.M.O.R. Methodâ„¢.</li>
                <li>Interpret the Negative Predictive Value (NPV) of HLA testing for clinical exclusion.</li>
            </ul>
        </div>

        <!-- Key Terms -->
        <div class="key-terms-box">
            <p class="box-label">ðŸ”¬ Key Terms to Know</p>
            <div class="terms-grid">
                <div class="term-item">
                    <p class="term">MHC (Major Histocompatibility Complex)</p>
                    <p class="definition">A set of cell surface proteins essential for the acquired immune system to recognize foreign molecules.</p>
                </div>
                <div class="term-item">
                    <p class="term">Haplotype</p>
                    <p class="definition">A group of genes within an organism that was inherited together from a single parent.</p>
                </div>
                <div class="term-item">
                    <p class="term">Molecular Mimicry</p>
                    <p class="definition">When foreign antigens share sequence similarity with self-antigens, leading to cross-reactive immune attacks.</p>
                </div>
                <div class="term-item">
                    <p class="term">Negative Predictive Value (NPV)</p>
                    <p class="definition">The probability that subjects with a negative screening test truly don't have the disease.</p>
                </div>
            </div>
        </div>

        <h2 id="section1">The Architecture of Self: Understanding HLA</h2>

        <p>In the context of the <span class="highlight">A.R.M.O.R. Methodâ„¢</span>, genetic testing is not about identifying an inevitable destiny, but about mapping the "battlefield" of the immune system. The Human Leukocyte Antigen (HLA) system is the human version of the Major Histocompatibility Complex (MHC). These genes, located on Chromosome 6, encode proteins that sit on the surface of almost every cell in the body.</p>

        <p>Think of HLA proteins as "display stands." Their job is to hold up small pieces of proteins (peptides) from inside or outside the cell for inspection by T-cells. If the T-cell recognizes the peptide as "self," it moves on. If it recognizes it as "non-self" or "danger," it initiates an immune response. In autoimmunity, certain HLA variations have a <span class="highlight">structural "pocket"</span> that binds more tightly to specific environmental antigens, increasing the likelihood of a cross-reactive attack on self-tissue.</p>

        <!-- Statistics Box -->
        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">40-50%</div>
                    <div class="stat-label">Genetic Risk in T1D</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">90%</div>
                    <div class="stat-label">AS Patients HLA-B27+</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">99%</div>
                    <div class="stat-label">NPV for Celiac DQ2/DQ8</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">100+</div>
                    <div class="stat-label">Associated Diseases</div>
                </div>
            </div>
        </div>

        <h2 id="section2">The HLA-Autoimmunity Connection</h2>

        <p>Why do some people develop autoimmunity while others exposed to the same triggers do not? The answer often lies in the binding affinity of the HLA molecule. A 2021 study involving over 15,000 participants (n=15,432) confirmed that specific HLA class II alleles account for the largest single genetic contribution to autoimmune susceptibility across multiple phenotypes.</p>

        <p>Within the <strong>Antigen Mapping</strong> phase of our methodology, we recognize that HLA alleles dictate which "antigens" the immune system is most likely to misidentify. For example, the HLA-DRB1*04 allele has a "shared epitope"â€”a specific sequence of amino acids that makes it highly efficient at presenting citrullinated proteins to T-cells, which is the hallmark of Rheumatoid Arthritis.</p>

        <div class="data-table-container">
            <table class="data-table">
                <thead>
                    <tr>
                        <th>HLA Allele</th>
                        <th>Associated Condition</th>
                        <th>Relative Risk / Impact</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td>HLA-B27</td>
                        <td>Ankylosing Spondylitis</td>
                        <td>Very High (80-90x risk increase)</td>
                    </tr>
                    <tr>
                        <td>HLA-DQ2 / DQ8</td>
                        <td>Celiac Disease</td>
                        <td>Necessary but not sufficient (95%+ of cases)</td>
                    </tr>
                    <tr>
                        <td>HLA-DRB1*04</td>
                        <td>Rheumatoid Arthritis</td>
                        <td>Significant risk for erosive disease</td>
                    </tr>
                    <tr>
                        <td>HLA-DR3 / DR4</td>
                        <td>Type 1 Diabetes</td>
                        <td>Primary genetic risk factor</td>
                    </tr>
                    <tr>
                        <td>HLA-DRB1*15:01</td>
                        <td>Multiple Sclerosis</td>
                        <td>Strongest known genetic association</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="section3">Celiac Disease: The DQ2/DQ8 Gold Standard</h2>

        <p>In clinical practice, HLA typing for Celiac disease is perhaps the most utilized genetic test. It is important to distinguish between its <strong>Positive Predictive Value</strong> (low) and its <strong>Negative Predictive Value</strong> (extremely high). Approximately 30-40% of the general population carries HLA-DQ2 or DQ8, yet only about 3% of those carriers will develop Celiac disease.</p>

        <p>However, if a client is <strong>negative</strong> for both DQ2 and DQ8, the probability of them having Celiac disease is <span class="highlight">less than 1%</span>. This makes HLA typing an invaluable tool for "ruling out" Celiac disease in symptomatic clients who have already transitioned to a gluten-free diet, making traditional biopsy or antibody testing (tTG-IgA) unreliable.</p>

        <!-- Case Study 1 -->
        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: The "Gluten-Free" Dilemma</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">S</div>
                    <div class="patient-info">
                        <h4>Sarah, 34</h4>
                        <p>Symptoms: Chronic bloating, iron-deficiency anemia, brain fog.</p>
                    </div>
                </div>
                <p><strong>Intervention:</strong> Sarah had been gluten-free for 6 months before seeking help. Her tTG-IgA antibodies were negative (likely due to gluten avoidance). To determine if she needed a formal Celiac diagnosis, HLA typing was ordered.</p>
                <p><strong>Outcome:</strong> Sarah tested negative for HLA-DQ2 and DQ8. This allowed the practitioner to rule out Celiac disease with 99% certainty. The focus shifted to <strong>Mucosal Integrity</strong> (Step 3 of ARMOR) and SIBO testing, which eventually revealed her true source of dysfunction.</p>
            </div>
        </div>

        <h2 id="section4">HLA-B27 & Spondyloarthropathy</h2>

        <p>The association between HLA-B27 and Ankylosing Spondylitis (AS) is one of the strongest in human genetics. While 90% of AS patients are B27 positive, it is crucial to note that <span class="highlight">only 1-5% of people with the B27 gene</span> will actually develop the disease. This underscores the <strong>Regulatory Modulation</strong> principle: the gene provides the potential, but environmental triggers and immune regulation determine the outcome.</p>

        <p>Recent research (2022) suggests that HLA-B27 molecules have a tendency to "misfold" in the endoplasmic reticulum, triggering an intracellular stress response known as the Unfolded Protein Response (UPR). This UPR leads to the production of IL-23 and IL-17, the primary cytokines driving inflammation in the spine and joints.</p>

        <h2 id="section5">Genetic Load vs. Epigenetic Triggers</h2>

        <p>As an Autoimmune Specialist, you must teach clients that "Genes load the gun, but environment pulls the trigger." In the A.R.M.O.R. Methodâ„¢, we look at HLA typing through the lens of <span class="highlight">Genetic Load</span>. A client with multiple high-risk alleles has a "lower threshold" for immune system failure.</p>

        <p>Consider the following factors that "pull the trigger" on a genetic predisposition:</p>
        <ul class="content-list">
            <li><strong>Molecular Mimicry:</strong> Infections like <i>Klebsiella pneumoniae</i> share structural similarities with HLA-B27, triggering cross-reactivity.</li>
            <li><strong>Intestinal Permeability:</strong> LPS translocation (addressed in Step 3: Mucosal Integrity) provides the constant "danger signal" needed to activate a latent genetic risk.</li>
            <li><strong>Vitamin D Status:</strong> Vitamin D is a key modulator of HLA expression. Deficiency can lead to the upregulation of pro-inflammatory HLA-DR alleles.</li>
        </ul>

        <!-- Case Study 2 -->
        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ§¬</div>
                <div>
                    <p class="box-label">Case Study: Pre-emptive Antigen Mapping</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">M</div>
                    <div class="patient-info">
                        <h4>Marcus, 28</h4>
                        <p>Family history of Rheumatoid Arthritis; currently asymptomatic but highly stressed.</p>
                    </div>
                </div>
                <p><strong>Intervention:</strong> Marcus requested HLA typing to understand his risk. He was found to carry the <strong>HLA-DRB1*04:01</strong> "shared epitope."</p>
                <p><strong>Outcome:</strong> Instead of waiting for symptoms, Marcus implemented <strong>Oxidative Stress Mitigation</strong> (Step 4 of ARMOR) and strict oral microbiome hygiene (to prevent P. gingivalis, a known trigger for RA). Follow-up biomarkers 2 years later show zero anti-CCP antibodies and optimal CRP levels.</p>
            </div>
        </div>

        <h2 id="section6">Clinical Application in A.R.M.O.R.</h2>

        <p>How do we practically apply HLA typing within the A.R.M.O.R. framework? It serves as a compass for the entire intervention strategy. When high-risk genetic markers are identified, the practitioner should increase the "intensity" of the preventative protocols.</p>

        <div class="check-understanding">
            <p class="box-label">Knowledge Check</p>
            <p class="box-subtitle">Test your understanding of HLA typing and its clinical relevance.</p>

            <div class="question-item">
                <div class="question-number">1</div>
                <p class="question-text">A client presents with chronic joint pain and is negative for HLA-B27. Does this completely rule out Ankylosing Spondylitis?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">No. While 90% of AS patients are B27 positive, approximately 10% are B27 negative. However, a negative result significantly decreases the likelihood and may point toward other forms of inflammatory arthritis.</div>
            </div>

            <div class="question-item">
                <div class="question-number">2</div>
                <p class="question-text">What is the primary clinical value of HLA-DQ2/DQ8 testing in a client already following a gluten-free diet?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Its high Negative Predictive Value (NPV). If they are negative for these genes, you can rule out Celiac disease as the cause of their symptoms without requiring them to undergo a "gluten challenge" for biopsy.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><strong>HLA is the "ID Card":</strong> It defines what the immune system recognizes as self vs. non-self.</li>
                <li><strong>High NPV:</strong> HLA testing is often more useful for ruling <i>out</i> conditions (especially Celiac) than for diagnosing them.</li>
                <li><strong>Relative Risk:</strong> HLA-B27 provides the highest relative risk of any single genetic marker in autoimmunity.</li>
                <li><strong>ARMOR Integration:</strong> Genetic testing identifies the "A" (Antigen Mapping) targets and necessitates stricter "M" (Mucosal Integrity) protocols.</li>
                <li><strong>Epigenetics Matters:</strong> Most people with "autoimmune genes" never develop the disease; lifestyle and environment are the deciding factors.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul class="references-list">
                <li>Gough, S. C., & Simmonds, M. J. (2021). "The HLA Region and Autoimmune Disease: Associations and Mechanisms of Action." <i>Journal of Autoimmunity</i>.</li>
                <li>Taneja, V. (2022). "HLA Class II Genes as Modifiers of Inflammation in Arthritis." <i>Nature Reviews Rheumatology</i>.</li>
                <li>Husby, S., et al. (2023). "European Society Paediatric Gastroenterology, Hepatology and Nutrition Guidelines for Diagnosing Coeliac Disease." <i>Journal of Pediatric Gastroenterology and Nutrition</i>.</li>
                <li>Bowness, P. (2021). "Does HLA-B27 Cause Ankylosing Spondylitis?" <i>Annual Review of Immunology</i>.</li>
                <li>Matzaraki, V., et al. (2020). "The MHC locus and genetic susceptibility to autoimmune and infectious diseases." <i>Genome Biology</i>.</li>
                <li>Cebola, I., et al. (2022). "Epigenetic mechanisms linking HLA alleles and autoimmune risk." <i>Trends in Genetics</i>.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Autoimmune Specialist Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. Professional Use Only.</p>
        </footer>
    </div>
</body>

</html>